BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 495799)

  • 1. The relation of time spent in drug abuse treatment to posttreatment outcome.
    Simpson DD
    Am J Psychiatry; 1979 Nov; 136(11):1449-53. PubMed ID: 495799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Client evaluations of drug abuse treatment in relation to follow-up outcomes.
    Simpson DD; Lloyd MR
    Am J Drug Alcohol Abuse; 1979; 6(4):397-411. PubMed ID: 549469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients.
    Simpson DD; Savage LJ
    Arch Gen Psychiatry; 1980 Aug; 37(8):896-901. PubMed ID: 7406653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agency differences in posttreatment outcomes: a follow-up of drug abuse treatment clients.
    Joe GW; Singh BK; Lehman W; Simpson DD; Sells SB
    Int J Addict; 1983 May; 18(4):523-38. PubMed ID: 6629561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for drug abuse. Follow-up outcomes and length of time spent.
    Simpson DD
    Arch Gen Psychiatry; 1981 Aug; 38(8):875-80. PubMed ID: 7259424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of opioid addicts 5 years after admission to drug abuse treatment.
    Bracy SA; Simpson DD
    Am J Drug Alcohol Abuse; 1982-1983; 9(2):115-27. PubMed ID: 7171076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Client types in different drug abuse treatments: comparisons of follow-up outcomes.
    Simpson DD; Savage LJ
    Am J Drug Alcohol Abuse; 1981-1982; 8(4):401-18. PubMed ID: 7348105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up evaluation of treatment of drug abuse during 1969 to 1972.
    Simpson DD; Savage LJ; Lloyd MR
    Arch Gen Psychiatry; 1979 Jul; 36(7):772-80. PubMed ID: 454093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment re-entry and outcomes of opioid addicts during a four-year follow-up after drug abuse treatment in the United States.
    Simpson DD; Savage LJ
    Bull Narc; 1980; 32(4):1-10. PubMed ID: 6912076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
    Sells SB; Simpson DD
    Bull Narc; 1979; 31(1):1-11. PubMed ID: 260891
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug abuse treatment process: a review of the literature.
    Allison M; Hubbard RL
    Int J Addict; 1985 Sep; 20(9):1321-45. PubMed ID: 3000959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between time spent in treatment and client outcomes from therapeutic communities.
    Condelli WS; Hubbard RL
    J Subst Abuse Treat; 1994; 11(1):25-33. PubMed ID: 8201630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug abuse treatment retention and process effects on follow-up outcomes.
    Simpson DD; Joe GW; Rowan-Szal GA
    Drug Alcohol Depend; 1997 Sep; 47(3):227-35. PubMed ID: 9306048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of time in drug abuse treatment and employment on posttreatment drug use and criminal activity.
    French MT; Zarkin GA; Hubbard RL; Rachal JV
    Am J Drug Alcohol Abuse; 1993; 19(1):19-33. PubMed ID: 8382448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?
    Kosten TR; Rounsaville BJ; Kleber HD
    Arch Gen Psychiatry; 1987 Mar; 44(3):281-4. PubMed ID: 3827521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women in drug abuse treatment programs: factors that influence retention at very early and later stages in two treatment modalities. A summary.
    Moise R; Reed BG; Conell C
    Int J Addict; 1981 Oct; 16(7):1295-300. PubMed ID: 7327794
    [No Abstract]   [Full Text] [Related]  

  • 20. Fixed and dynamic predictors of client retention in therapeutic communities.
    Condelli WS; De Leon G
    J Subst Abuse Treat; 1993; 10(1):11-6. PubMed ID: 8383775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.